Transcutaneous carbon dioxide (CO2) application for malignant bone and soft tissue tumor (sarcoma)
Phase 1
Recruiting
- Conditions
- Malignant bone and soft tissue tumor (Sarcoma)sarcoma
- Registration Number
- JPRN-jRCTs052180038
- Lead Sponsor
- Fukase Naomasa
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
(1) Patients who have been histologically diagnosed as either malignant bone tumor or malignant soft tissue tumor
(2) Age 16 yo or more
(3) More than 4 weeks since any prior therapy
(4) PS 0-1
(5) The patient have consented to the study in the document
Exclusion Criteria
(1) Skin ulcer or pathological fracture in the treated area
(2) Peripheral arterial disease or ischemic disease in the affected limb
(3) Skin disease in the affected limb
(4) Active infectious disease in the affected limb
(5) Other medical or psychological unsuitable reasons
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method